If you are having trouble reading this email, read the online version.
Catalent corporate logo in blue lettering with white background

catalent.com

Find Out Which 11 Biotechs Stand Out From the Pack

Banner promoting Endpoints 11 event on September 20th from 5:45 to 10:30 pm in Boston. Sponsored by Catalent and Advance. Reserve Your Spot. Banner is designed in shades of blue, gold and white.

Catalent is elated to share that its CEO and President, Alessandro Maselli, will have the honor of co-hosting this year’s Endpoints 11 award ceremony alongside Endpoints Founder and Editor, John Carroll.


Catalent congratulates all the nominees for this prestigious recognition and looks forward to shedding light on industry-leading pioneers in healthcare.

Reserve Your Spot

In Other News: Catalent Congratulates its

Partners for Their Recent Approvals

Regeneron Receives Two FDA Approvals

Catalent congratulates Regeneron for their two recent FDA approvals: a treatment for patients suffering from wet age-related macular degeneration (WAMD), diabetic edema (DME), and diabetic retinopathy (DR); and the first treatment for Chaple disease, a rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms. Catalent stands ready in helping to manufacture these products in support of their patients in need.

Image of a blue shield with shades of purple outlining and purple, green and blue syringes and vials in the background
Read the Press Releases

Sarepta’s First FDA-Approved Gene Therapy Treatment Administered

Catalent congratulates Sarepta Therapeutics on the administration of the first commercial dose of the first FDA-approved gene therapy treatment for patients aged 4 to 5 years old with Duchenne Muscular Dystrophy. Catalent’s dedicated packaging team for advanced therapies was proud to help make the dose available to the first patients before they turned 6 and would no longer be eligible under the current label.

icon of a blue ribbon on a white background
Learn More

Looking to Connect at an Upcoming Event?

We look forward to meeting you at some of our upcoming events to discuss your program needs.

View All Our Events
Schedule a Meeting

Every Molecule has a challenge. We have a solution.


Challenge Us

or call +1 877 891 9609 to speak with one of our experts today!


To unsubscribe or manage your subscriptions, please click here.


For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at sales@catalent.com, or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers.


Catalent Pharma Solutions respects your privacy.


Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement of the website, its owner(s) or the content.


© 2023, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved.